Abstract
One of the major challenges of gene therapy—an approach to treat diseases caused by faulty genes—is a lack of technologies that deliver healthy gene copies to target tissues and cells. Some commonly used approaches include viral vectors or coating therapeutic nucleic acids with lipid-based nanoparticles to pass through cell membranes, but these technologies have had limited success. A revolutionary tool, the CRISPR–Cas gene-editing system, offers tremendous promise, but it too suffers from problems with delivery. Another tool, called ‘SEND’ (for ‘selective endogenous encapsidation for cellular delivery’), seems to offer a better solution. The SEND system uses endogenous genetic components to package mRNA cargoes to deliver them to other cells via virus-like particles (VLPs). The SEND-VLP tool has enormous potential as a gene-therapy tool, if the endogenous components of SEND can be repurposed to produce VLPs containing therapeutic cargoes. However, several aspects of this newly identified phenomenon are not yet fully understood. Genetically engineered mouse (GEM) models, expressing different combinations of SEND components in a controllable and inducible fashion, could serve as valuable tools to understand more about this tool and to repurpose it for gene-therapy applications. In this Perspective, we discuss how GEM models and mouse molecular genetics tools could be used for SEND-VLP research.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
No original data or code was generated or used for this paper.
References
Cong, L. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).
Mali, P. RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013).
Uddin, F., Rudin, C. M. & Sen, T. CRISPR gene therapy: applications, limitations, and implications for the future. Front. Oncol. 10, 1387 (2020).
Segel, M. et al. Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery. Science 373, 882–889 (2021).
Riecken, K., Głów, D. & Fehse, B. How to package and SEND mRNA: a novel “humanized” vector system based on endogenous retroviruses. Signal Transduct. Target. Ther. 6, 384 (2021).
Kingwell, K. Hitting SEND on mRNA delivery. Nat. Rev. Drug Discov. 20, 738–738 (2021).
Yung, N. K., Maassel, N. L., Ullrich, S. J., Ricciardi, A. S. & Stitelman, D. H. A narrative review of in utero gene therapy: advances, challenges, and future considerations. Transl. Pediatr. 10, 1486–1496 (2021).
Ono, R. et al. Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality. Nat. Genet. 38, 101–106 (2006).
Pastuzyn, E. D. et al. The neuronal gene Arc encodes a repurposed retrotransposon Gag protein that mediates intercellular RNA transfer. Cell 172, 275–288.e18 (2018).
Dejneka, N. S. et al. In utero gene therapy rescues vision in a murine model of congenital blindness. Mol. Ther. 9, 182–188 (2004).
Ito, H. et al. In utero gene therapy rescues microcephaly caused by Pqbp1-hypofunction in neural stem progenitor cells. Mol. Psychiatry 20, 459–471 (2015).
Wang, S. et al. AAV gene therapy prevents and reverses heart failure in a murine knockout model of Barth syndrome. Circ. Res. 126, 1024–1039 (2020).
Kim, M.-A. et al. Methionine sulfoxide reductase B3-targeted in utero gene therapy rescues hearing function in a mouse model of congenital sensorineural hearing loss. Antioxid. Redox Signal. 24, 590–602 (2016).
Platt, R. J. et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159, 440–455 (2014).
Bowling, S. et al. An engineered CRISPR-Cas9 mouse line for simultaneous readout of lineage histories and gene expression profiles in single cells. Cell 181, 1410–1422.e27 (2020).
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global double-fluorescent Cre reporter mouse. Genesis 45, 593–605 (2007).
Miura, H. et al. Novel reporter mouse models useful for evaluating in vivo gene editing and for optimization of methods of delivering genome editing tools. Mol. Ther. Nucleic Acids 24, 325–336 (2021).
Friedrich, G. & Soriano, P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev. 5, 1513–1523 (1991).
Indra, A. K. et al. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ERT and Cre-ERT2 recombinases. Nucleic Acids Res. 27, 4324–4327 (1999).
Ohtsuka, M. et al. Fluorescent transgenic mice suitable for multi-color aggregation chimera studies. Cell Tissue Res. 350, 251–260 (2012).
Quadros, R. M. et al. Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins. Genome Biol. 18, 92 (2017).
Miura, H., Quadros, R. M., Gurumurthy, C. B. & Ohtsuka, M. Easi-CRISPR for creating knock-in and conditional knockout mouse models using long ssDNA donors. Nat. Protoc. 13, 195–215 (2018).
Gurumurthy, C. B. et al. Genetically modified mouse models to help fight COVID-19. Nat. Protoc. 15, 3777–3787 (2020).
Gurumurthy, C. B., Saunders, T. L. & Ohtsuka, M. Designing and generating a mouse model: frequently asked questions. J. Biomed. Res. 35, 76–90 (2021).
Gurumurthy, C. B. CRISPR: a versatile tool for both forward and reverse genetics research. Hum. Genet. 135, 971–976 (2016).
Kuhn, M., Santinha, A. J. & Platt, R. J. Moving from in vitro to in vivo CRISPR screens. Gene Genome Ed. 2, 100008 (2021).
Chen, S. et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160, 1246–1260 (2015).
Iwano, S. et al. Single-cell bioluminescence imaging of deep tissue in freely moving animals. Science 359, 935–939 (2018).
Acknowledgements
We thank Guy Richardson (University of Sussex), Suzanne Mansour (University of Utah) and Hiromi Miura (Tokai University) for critical reading of the manuscript and Nick May (TypeRight) and James M. Burbach (University of Nebraska Medical Center) for copy editing. C.B.G. is funded by NIH grants R35HG010719, R21GM129559, R21AI143394 and R21DA046831. M.O. is funded by JSPS KAKENHI (20K21551) and Takeda Science Foundation (2020).
Author information
Authors and Affiliations
Contributions
C.B.G. and M.O. conceived the overall idea and wrote the manuscript. R.M.Q. generated a figure schematic.
Corresponding authors
Ethics declarations
Competing interests
A provisional patent on some of the ideas in this article will be submitted in which C.B.G. and M.O. will be listed as inventors.
Peer review
Peer review information
Nature Protocols thanks Rosie Bunton-Stasyshyn, Xucheng Hou and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Additional initial assessment was performed by informal referee Horacio Cabral.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related links
Key references using this protocol
Segel, M. et al. Science 373, 882–889 (2021); https://doi.org/10.1126/science.abg6155
Quadros, R. M. et al. Genome Biol. 18, 92 (2017); https://doi.org/10.1186/s13059-017-1220-4
Miura, H. et al. Nat. Protoc. 13, 195–215 (2018); https://doi.org/10.1038/nprot.2017.153
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gurumurthy, C.B., Quadros, R.M. & Ohtsuka, M. Prototype mouse models for researching SEND-based mRNA delivery and gene therapy. Nat Protoc 17, 2129–2138 (2022). https://doi.org/10.1038/s41596-022-00721-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41596-022-00721-7